title: [Biosimilars - Potential, risks and open questions].
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D059451:Biosimilar Pharmaceuticals / Q000009:adverse effects* / Q000191:economics / Q000592:standards* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017046:Cost Savings / Q000191:economics / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence; D016527:Drug Costs / Q000331:legislation & jurisprudence / Q000592:standards; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics / Q000331:legislation & jurisprudence; D061214:Patient Safety / Q000592:standards; D011785:Quality Assurance, Health Care / Q000191:economics / Q000331:legislation & jurisprudence / Q000592:standards; D013810:Therapeutic Equivalency
chemical_list: D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals
vernacular_title: Biosimilars- Potenziale, Risikenund und offene Fragen.